An analysis of the quarterly moving averages of antibody and RNA prevalence in the population reveals a decreasing trend over time, crossing zero between 2024 and 2026.
1
—
—
An analysis of the quarterly moving averages of antibody and RNA prevalence in the population reveals a decreasing trend over time, crossing zero between 2024 and 2026.